University Hospital Essen

addEssen, Germany
( 7/10 from votes )
Prof. Dr. Boris Hadaschik

Head of the Department

Prof. Dr. Boris Hadaschik

Department of Urology

Department of Urology at University Hospital Essen provides care for patients with diseases of the kidney and bladder as well as tumors of prostate, kidney, and bladder. The department consists of 45 beds, 3 monitoring units, and 3 operating theatres. The department is in cooperation with the Department of Anaesthesiology for optimum care for patients during surgeries. It is certified as a training center by the European Board of Urology for fresh graduates and senior physicians. It consists of the Prostate Cancer Center which is certified by the German Cancer Society.
With Prof. Dr. med. Boris Hadaschik as the head of the department, more than 8,000 patients are treated there every year, more than 3,000 of which are inpatients. A special feature of this department is the Da Vinci surgery which they have been performing since 2010. The Da Vinci surgery reduces pain, blood loss, hospital stay after surgery and provides faster recovery. The department also offers gender-adjusting operations.

Department of Urology at University Hospital Essen is specialized in the diagnosis and treatment of:

•    Kidney tumors
•    Urinary bladder tumors
•    Benign prostatic hyperplasia
•    Prostate cancer
•    Testicular tumors
•    Urinary incontinence
•    Congenital malformation of urogenital organs
•    Infertility
•    Erectile dysfunction
•    External genital deformity
•    Urinary stones
•    Varicocele

  • Prof. Boris Hadaschik studied medicine in Heidelberg, Louisville, Detroit, and New Orleans. Afterward, he trained in Surgery and Urology in Heidelberg and Mainz.
  • In 2006, Boris Hadaschik was awarded a two-year postdoctoral research fellowship at the Vancouver Prostate Centre from the German Research Foundation.
  • He obtained the German Urological Association’s highest scientific award, the Maximilian Nitze Prize, for his work regarding "Novel intravesical agents against non-muscle invasive bladder cancer in a validated orthotopic mouse model".
  • In 2010, Boris Hadaschik became an Associate Professor in the Department of Urology at the University Hospital Heidelberg.
  • His main interests lie in the development of prostate cancer diagnostics (for example, imaging-guided biopsy) and therapy (for example, molecularly-targeted radiopharmaceuticals) to improve and customize cancer treatment and its outcomes.
  • Prof. Boris Hadaschik is a Co-Founder of the Ginsburg Study Group for Comprehensive Prostate Diagnostics and a Member of several international Working Groups to optimize MRI-targeted prostate biopsy.
  • In addition, he is a Principal Investigator of the German multicentre PROBASE trial for prospective randomized evaluation of risk-adapted prostate-specific antigen screening in 50,000 young men.